INTERNATIONAL PATENT: LAUNXP BIOMEDICAL CO., LTD., 朗齐生物医学股份有限公司 FILES APPLICATION FOR "USE OF DULOXETINE AND CHEMOTHERAPEUTIC DRUG IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER"

GENEVA, Nov. 30 -- LAUNXP BIOMEDICAL CO., LTD. (10F., No. 51, Sec. 2, Gongyi Rd., Nantun Dist., Taichung CityTaiwan 408), 朗齐生物医学股份有限公司 (中国台湾省台中市南屯区公益路二段51号10楼) filed a patent application (PCT/CN2025/096659) for "USE OF DULOXETINE AND CHEMOTHERAPEUTIC DRUG IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER" on May 22, 2025. With publication no. WO/2025/242178, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Pa...